Record Revenue of $273 Million and EPS of $1.17Record Bookings of $294 Million and Book-to-Bill of 1.08-to-1


FEI Company (NASDAQ:FEIC) today reported results for the fourth quarter of 2015.  Fourth quarter revenue of $273 million was up 2.7% compared with $265 million for fourth quarter of 2014.   Movements in foreign exchange rates negatively impacted revenue for the fourth quarter of 2015 by approximately $16 million.  Excluding the impact of foreign exchange movements and $1.7 million of revenue related to acquisitions, fourth quarter organic revenue was up 8.2% compared with the fourth quarter of 2014. 

Diluted earnings per share computed on the basis of accounting principles generally accepted in the United States ("GAAP") were $1.17 for the fourth quarter of 2015, compared with $0.79 in the fourth quarter of 2014.  Net income for the quarter was $48 million compared with $33 million in the fourth quarter of 2014.  

On December 10, 2015, the company completed the acquisition of DCG Systems.  Included in fourth quarter 2015 results is $1.0 million of DCG revenue and a net negative impact to net income of $3.0 million, or $0.07 per share.

The company’s backlog of orders at the end of the fourth quarter of 2015 was $591 million, compared with $536 million at the end of the fourth quarter of 2014 and $562 million at the end of the third quarter of 2015.  Bookings for the fourth quarter of 2015 were a record $294 million, resulting in a book-to-bill ratio of 1.08-to-1.

For the full year 2015, revenue was $930 million compared with $956 million for 2014.  Excluding the impact of $55 million related to negative foreign exchange movements and $4.1 million of revenue related to acquisitions, 2015 organic revenue was up 2.6% compared with 2014.  Bookings were $996 million compared with $1.05 billion for 2014.  Adjusted EBITDA for 2015 was $217 million compared with $199 million for 2014.  A reconciliation of adjusted EBITDA to GAAP operating income is included in a table attached to this press release.  Net income for 2015 was $124 million or $2.96 per diluted share, compared with $105 million or $2.47 per diluted share for 2014. 

Net cash provided by operating activities for the fourth quarter of 2015 was $70 million, unchanged from the fourth quarter of 2014.  During the quarter, the company paid cash dividends of $12 million, invested $6.9 million on plant and equipment and repurchased 443,000 shares of its common stock at an average price of $75.77. 

In 2015, net cash provided by operating activities was $204 million, compared with $143 million in 2014.  For the full year, the company paid cash dividends of $46 million, invested $17 million in plant and equipment and repurchased 1.4 million shares of its common stock at an average price of $76.78.  Total cash, investments and restricted cash at the end of 2015 was $351 million. 

“2015 finished on a positive note with record revenue, operating margin and earnings per share in the fourth quarter,” commented Don Kania, president and CEO. “The strong results in the quarter were driven by our Science segment, with record orders and revenue from life sciences customers.  

“As we look to 2016, we see improved organic revenue growth driving increased earnings and cash flow for FEI.  We are especially excited about the adoption of cyro-EM by life sciences customers and there is opportunity for an improved back half of the year in the semiconductor market as spending picks up at our larger customers.”

Outlook

For full year 2016, the company expects reported revenue to be in the range of $1.02 billion to $1.05 billion.  On an organic basis, excluding revenue from DCG and the expected negative impact of a stronger U.S dollar, revenue is expected to grow in the range of 3.5% to 6.5%, compared with 2015.  Adjusted EBITDA is expected to be in the range of $235 million to $245 million.  GAAP earnings per fully diluted share are expected to be in the range of $3.55 to $3.70.  This range is based on an expected tax rate for the full year of approximately 21%. 

For the first quarter of 2016, the company expects reported revenue to be in the range of $215 million to $225 million.  On an organic basis, excluding revenue from DCG and the expected negative impact of a stronger U.S. dollar, first quarter 2016 revenue is expected to be in the range of flat to down 4.0% compared with the first quarter of 2015.  First quarter GAAP earnings per fully diluted share are expected to be in the range of $0.46 to $0.57. 

Investor Conference Call - 2:00 p.m. Pacific Time, Tuesday, February 2, 2016

Parties interested in listening to FEI's quarterly conference call may do so by dialing 1-877-407-8293 (U.S., toll-free) or +1-201-689-8349 (international and toll), with the conference title:  FEI Fourth Quarter Earnings Conference Call.  The call can also be accessed via the web by going to FEI's Investor Relations page at http://investor.fei.com/event, where the webcast will also be archived.

Safe Harbor Statement

This news release contains forward-looking statements that include guidance for revenue and/or earnings per share for the first quarter of 2016 and full year 2016, the impact of certain items on our results for these periods, statements regarding our sources of revenue, our investments and expenditures, foreign currency exchange rates, assumptions about tax rates, the allocation of our resources and expenditures, expectations for performance from the acquisition of DCG, and developments, trends, and opportunities in certain markets.  Forward-looking statements may also be identified by words and phrases that refer to future expectations, such as "guidance", "guiding", "forecast", "toward", "plan", "expect", "are expected", "is expected", "believe", "anticipate", "will", "projecting", "look forward", “continue to see”, “outlook” and other similar words and phrases. Factors that could affect these forward-looking statements include, but are not limited to:  the global economic environment, particularly continued slower growth in China and emerging markets; lower than expected customer orders, including for recently-introduced products; potential weakness of the Science and Industry market segments, including continued weakness in the oil and gas sector of the Industry segment resulting from lower oil prices; fluctuations in foreign exchange rates, which, among other things, can affect revenues,  margins, bookings, backlog and the competitive pricing of our products; cyclical and other changes and increased volatility in the semiconductor industry, which is a major component of Industry market segment revenue; failure to achieve the anticipated benefits of the DCG acquisition; changes in backlog and the timing of shipments from backlog, which may create forecasting challenges; potential delayed or reduced governmental spending to support expected orders; potential disruption in the company's operations due to organizational changes; the relative mix of higher-margin and lower-margin products; potential for increased volatility and challenges in forecasting resulting from larger sales transactions, cancellations and rescheduling of orders by customers; risks associated with a high percentage of the company's revenue coming from book and ship business, when the order for a product is placed by the customer in the same quarter as the planned shipment, and risks associated with building and shipping a high percentage of the company’s quarterly revenue in the last month of the quarter; delays in meeting all accounting requirements for revenue recognition; the ongoing determination of the effectiveness of foreign exchange hedge transactions; the relative mix of U.S. and non-U.S. sales; additional costs related to future merger and acquisition activity; failure of the company to achieve anticipated benefits of acquisitions and collaborations, including failure to achieve financial goals and integrate acquisitions successfully; reduced profitability due to failure to achieve or sustain margin improvement in service or product manufacturing; potential disruption in manufacturing or unexpected additional costs due to the transition from older to newer products; failure to achieve improved operational efficiency and other benefits from infrastructure investments and restructuring activities; potential additional restructurings, realignments and reorganizations;  inability to deploy products as expected or delays in shipping products due to technical problems or barriers, especially with regard to recently introduced TEM products; bankruptcy or insolvency of customers or suppliers; and changes in U.S. and foreign tax rates and laws, accounting rules regarding taxes or agreements with tax authorities. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.

About FEI:

FEI Company (Nasdaq:FEIC) designs, manufactures and supports a broad range of high-performance microscopy workflow solutions that provide images and answers at the micro-, nano- and picometer scales. Its innovation and leadership enable customers in industry and science to increase productivity and make breakthrough discoveries. Headquartered in Hillsboro, Ore., USA, FEI has over 3,000 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.

FEI Company and Subsidiaries
Consolidated Balance Sheets
(In thousands)
(Unaudited)
 
  December 31,  2015   December 31,  2014
Assets      
Current Assets:      
Cash and cash equivalents $ 300,911     $ 300,507  
Short-term investments in marketable securities     61,688  
Short-term restricted cash 19,119     15,698  
Receivables, net 213,128     227,354  
Inventories, net 170,513     176,440  
Deferred tax assets 10,566     8,225  
Other current assets 33,614     35,503  
Total current assets 747,851     825,415  
Long-term investments in marketable securities 8,677     85,865  
Long-term restricted cash 22,113     38,369  
Property plant and equipment, net 155,608     163,794  
Intangible assets, net 35,943     54,111  
Goodwill 145,607     170,773  
Deferred tax assets 6,719     6,605  
Long-term inventories 47,109     50,731  
Other assets, net 180,222     22,155  
Total Assets $ 1,349,849     $ 1,417,818  
Liabilities and Shareholders' Equity      
Current Liabilities:      
Accounts payable $ 58,708     $ 78,308  
Accrued payroll liabilities 38,643     38,599  
Accrued warranty reserves 14,107     13,005  
Deferred revenue 101,155     96,924  
Income taxes payable 12,124     5,299  
Accrued restructuring and reorganization 655     9,161  
Other current liabilities 52,630     56,146  
Total current liabilities 278,022     297,442  
Long-term deferred revenue 44,745     34,021  
Deferred tax liabilities 5,187     9,576  
Other liabilities 31,819     35,454  
Shareholders' Equity:      
Preferred stock - 500 shares authorized; none issued and outstanding      
Common stock - 70,000 shares authorized; 40,855 and 41,797 shares issued and outstanding, no par value 533,062     607,250  
Retained earnings 538,053     461,586  
Accumulated other comprehensive loss (81,039 )   (27,511 )
Total shareholders’ equity 990,076     1,041,325  
Total Liabilities and Shareholders' Equity $ 1,349,849     $ 1,417,818  

FEI Company and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
 
  Thirteen Weeks Ended   Fifty-Two Weeks Ended
  December 31,  2015   December 31,  2014   December 31,  2015   December 31,  2014
Net Sales:              
Products $ 206,164     $ 205,207     $ 685,651     $ 722,666  
Service 66,402     60,098     244,481     233,614  
Total net sales 272,566     265,305     930,132     956,280  
Cost of Sales:              
Products 101,106     106,718     336,071     369,043  
Service 38,522     35,188     139,470     139,082  
Total cost of sales 139,628     141,906     475,541     508,125  
Gross profit 132,938     123,399     454,591     448,155  
Operating Expenses:              
Research and development 25,294     25,434     95,569     102,613  
Selling, general and administrative 49,181     49,170     181,563     197,682  
Impairment of goodwill and long-lived assets         26,596      
Restructuring and reorganization 2     7,201     (563 )   18,459  
Total operating expenses 74,477     81,805     303,165     318,754  
Operating Income 58,461     41,594     151,426     129,401  
Other Expense, Net (705 )   (564 )   (3,634 )   (2,471 )
Income Before Income Taxes 57,756     41,030     147,792     126,930  
Income Tax Expense 9,509     7,639     23,783     21,866  
Net Income $ 48,247     $ 33,391     $ 124,009     $ 105,064  
Basic Net Income Per Share $ 1.18     $ 0.80     $ 2.99     $ 2.50  
Diluted Net Income Per Share $ 1.17     $ 0.79     $ 2.96     $ 2.47  
Weighted Average Shares Outstanding:              
Basic 40,887     41,726     41,419     41,969  
Diluted 41,256     42,221     41,839     42,528  

FEI Company and Subsidiaries
Consolidated Statements of Operations
(Unaudited)
 
  Thirteen Weeks Ended (1)   Fifty-Two Weeks Ended (1)
  December 31,  2015   December 31,  2014   December 31,  2015   December 31,  2014
Net Sales:              
Products 75.6 %   77.3 %   73.7 %   75.6 %
Service 24.4     22.7     26.3     24.4  
Total net sales 100.0 %   100.0 %   100.0 %   100.0 %
Cost of Sales:                      
Products 37.1 %   40.2 %   36.1 %   38.6 %
Service 14.1     13.3     15.0     14.5  
Total cost of sales 51.2 %   53.5 %   51.1 %   53.1 %
Gross Margin:                      
Products 51.0 %   48.0 %   51.0 %   48.9 %
Service 42.0     41.4     43.0     40.5  
Gross margin 48.8     46.5     48.9     46.9  
Operating Expenses:                      
Research and development 9.3 %   9.6 %   10.3 %   10.7 %
Selling, general and administrative 18.0     18.5     19.5     20.7  
Impairment of goodwill and long-lived assets         2.9      
Restructuring and reorganization     2.7     (0.1 )   1.9  
Total operating expenses 27.3 %   30.8 %   32.6 %   33.3 %
Operating Income 21.4 %   15.7 %   16.3 %   13.5 %
Other Expense, Net (0.3 )%   (0.2 )%   (0.4 )%   (0.3 )%
Income Before Income Taxes 21.2 %   15.5 %   15.9 %   13.3 %
Income Tax Expense 3.5 %   2.9 %   2.6 %   2.3 %
Net Income 17.7 %   12.6 %   13.3 %   11.0 %

(1)       Percentages may not add due to rounding.

FEI Company and Subsidiaries
Consolidated Summary of Cash Flows
(In thousands)
(Unaudited)
 
  Thirteen Weeks Ended   Fifty-Two Weeks Ended
  December 31,  2015   December 31,  2014   December 31,  2015   December 31,  2014
Net Income $ 48,247     $ 33,391     $ 124,009     $ 105,064  
Depreciation 6,437     6,663     24,801     29,042  
Amortization 2,745     3,812     11,225     14,290  
Stock-based compensation 5,764     5,676     22,379     23,132  
Impairment of goodwill and long-lived assets     1,097     26,596     1,379  
Other changes in working capital 6,555     19,668     (4,530 )   (29,998 )
Net cash provided by operating activities 69,748     70,307     204,480     142,909  
Acquisition of property, plant and equipment (6,914 )   (14,052 )   (17,023 )   (49,481 )
Payments for acquisitions, net of cash acquired (161,811 )       (167,188 )   (65,049 )
Other investing activities 67,518     15,681     144,360     (2,285 )
Net cash (used in) provided by investing activities (101,207 )   1,629     (39,851 )   (116,815 )
Dividends paid on common stock (12,333 )   (10,443 )   (45,673 )   (31,062 )
Repurchases of common stock (34,664 )   (22,208 )   (107,238 )   (62,523 )
Other financing activities 2,465     (1,757 )   11,139     9,183  
Net cash used in financing activities (44,532 )   (34,408 )   (141,772 )   (84,402 )
Effect of exchange rate changes (4,956 )   (9,462 )   (22,453 )   (25,355 )
(Decrease) increase in cash and cash equivalents (80,947 )   28,066     $ 404     $ (83,663 )
Cash and Cash Equivalents:              
Beginning of period 381,858     272,441     300,507     384,170  
End of period $ 300,911     $ 300,507     $ 300,911     $ 300,507  
Supplemental Cash Flow Information:              
Cash paid for income taxes, net $ 2,768     $ 2,525     $ 25,190     $ 16,983  
Accrued purchases of plant and equipment 2,193     700     2,193     700  
Dividends declared but not paid 12,257     10,385     12,257     10,385  

FEI Company and Subsidiaries
Adjusted EBITDA Reconciliation
(In thousands)
(Unaudited)
 
  Thirteen Weeks Ended   Fifty-Two Weeks Ended
  December 31,  2015   December 31,  2014   December 31,  2015   December 31,  2014
GAAP Operating Income $ 58,461     $ 41,594     $ 151,426     $ 129,401  
Add: Depreciation 6,437     6,663     24,801     29,042  
Add: Amortization 2,745     3,812     11,225     14,290  
EBITDA 67,643     52,069     187,452     172,733  
Add: Impairment of goodwill and long-lived assets         26,596      
Add: Restructuring and integration costs 562     9,760     (3 )   26,559  
Add: DCG transaction costs 3,257         3,257      
Adjusted EBITDA $ 71,462     $ 61,829     $ 217,302     $ 199,292  

FEI Company and Subsidiaries
Supplemental Data Table
($ in millions, except per share amounts)
(Unaudited)
 
  Thirteen Weeks Ended   Fifty-Two Weeks Ended
  December 31,   December 31,   December 31,   December 31,
  2015   2014   2015   2014
Income Statement Highlights:              
Consolidated sales $ 272.6     $ 265.3     $ 930.1     $ 956.3  
Gross margin 48.8 %   46.5 %   48.9 %   46.9 %
Net income $ 48.2     $ 33.4     $ 124.0     $ 105.1  
Diluted net income per share $ 1.17     $ 0.79     $ 2.96     $ 2.47  
                               
Sales and Bookings Highlights:                              
Sales by Segment                              
Industry Group $ 109.6     $ 109.5     $ 446.3     $ 450.2  
Science Group 163.0     155.8     483.8     506.1  
Sales by Geography                              
USA & Canada $ 80.0     $ 75.9     $ 297.7     $ 305.6  
Europe 87.0     80.6     246.9     267.8  
Asia-Pacific and Rest of World 105.6     108.8     385.5     382.9  
Gross Margin by Segment                              
Industry Group 51.6 %   49.9 %   52.2 %   51.1 %
Science Group 46.9     44.1     45.8     43.1  
Bookings and Backlog                              
Bookings - Total $ 294.3     $ 273.3     $ 995.6     $ 1,046.4  
Book-to-bill Ratio 1.08     1.03     1.07     1.09  
Backlog - Total $ 590.6     $ 535.6     $ 590.6     $ 535.6  
Backlog - Service 173.5     170.8     173.5     170.8  
Bookings by Segment                              
Industry Group $ 106.2     $ 102.3     $ 470.7     $ 493.4  
Science Group 188.1     171.0     524.9     553.0  
Bookings by Geography                              
USA & Canada $ 105.1     $ 69.0     $ 348.6     $ 303.5  
Europe 93.2     88.3     259.3     321.8  
Asia-Pacific and Rest of World 96.0     116.0     387.6     421.1  
                               
Balance Sheet and Other Highlights:                              
Cash, equivalents, investments, restricted cash $ 350.8     $ 502.1     $ 350.8     $ 502.1  
Days sales outstanding (DSO) 71     78     71     78  
Days in inventory 149     152     149     152  
Days in payables (DPO) 38     50     38     50  
Cash Cycle (DSO + Days in Inventory - DPO) 182     180     182     180  
Working capital $ 469.8     $ 528.0     $ 469.8     $ 528.0  
Headcount (permanent and temporary) 3,060     2,660     3,060     2,660  
Euro average rate 1.10     1.25     1.11     1.33  
Euro ending rate 1.09     1.21     1.09     1.21  
Yen average rate 121.44     113.50     121.02     105.45  
Yen ending rate 120.39     119.59     120.39     119.59  

 

For more information contact:

FEI Company
Jason Willey
Sr. Director, Investor Relations and Corporate Development
(503) 726-2533
jason.willey@fei.com
Fei Company (MM) (NASDAQ:FEIC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Fei Company (MM) Charts.
Fei Company (MM) (NASDAQ:FEIC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Fei Company (MM) Charts.